Related Experiment Video
Updated: Jun 23, 2025
Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells
Published on: July 29, 2016
Clinical and pathological aspects of toxic myopathies
Mégane Le Quang1, Guilhem Solé2, Marie-Laure Martin-Négrier1
1Department of Pathology, University Hospital (CHU) of Bordeaux, Pellegrin Hospital, Place Amélie Raba Léon, 33000, Bordeaux, France.
Abstract:
As the most frequent cause of acquired myopathy, toxic myopathies are characterised by clinicopathological features that vary depending on the mode of action of the drugs or toxins involved. Although a large number of substances can induce myotoxicity, the main culprits are statins, alcohol, and corticosteroids. A rigorous, well-organised diagnostic approach is necessary to obtain a rapid diagnosis. For early diagnosis and management, it is important for clinicians to be aware that most toxic myopathies are potentially reversible, and the goal of treatment should be to avoid serious muscle damage.
Insights
Toxic myopathies, often caused by statins, alcohol, or corticosteroids, present diverse symptoms. Early diagnosis and intervention are key, as these drug-induced muscle conditions are frequently reversible.
Area of Science:
- Neurology
- Toxicology
- Pathology
Background:
- Acquired myopathies are frequently caused by toxic agents.
- Clinicopathological features of toxic myopathies depend on the specific drug or toxin.
- Statins, alcohol, and corticosteroids are primary causes of drug-induced myotoxicity.
Purpose of the Study:
- To highlight the diagnostic challenges and clinical awareness required for toxic myopathies.
- To emphasize the potential reversibility and management goals for toxic myopathies.
Main Methods:
- Review of clinicopathological features associated with various myotoxic substances.
- Analysis of diagnostic approaches for identifying drug-induced myopathies.
- Emphasis on clinical recognition of common causative agents like statins, alcohol, and corticosteroids.
Main Results:
- Toxic myopathies exhibit varied presentations based on the causative agent.
- A structured diagnostic process is essential for timely identification.
- Most toxic myopathies are reversible if diagnosed and managed promptly.
Conclusions:
- Clinicians must be aware of the diverse causes and presentations of toxic myopathies.
- Prompt diagnosis and avoidance of muscle-damaging agents are crucial for successful treatment.
- Early intervention can lead to the reversal of muscle damage in most toxic myopathy cases.
Related Concept Videos
01:28Disorders of the Skeletal Muscle
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
01:15Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
01:26Toxic Reactions: Overview
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
01:20Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
01:26Chemical Synapses
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
01:15Parkinson's Disease: Overview